Stronger Sell Today ALNY ranks #4852 as SELL CANDIDATE #4852 Weaker Sell

Alnylam Pharmaceuticals stock forecast

ALNY stock forecast

Friday June 14, 2019 Change -1.70% Price $70.03
Chart period: 2019-03-15 - 2019-06-14
VOLUME
Sell
TREND
Sell
MV LONG
Sell

MV SHORT
Sell

PIVOT
Sell

MACD
Buy

Will ALNY stock price go up or down on Mon, 17 Jun 2019?

Predict

Alnylam Pharmaceuticals Forecast and Stock Analysis

Technical ALNY stock analysis for Friday June 14, 2019.

Sell candidate since 2019-06-06 Loss -1.09%


Alnylam Pharmaceuticals fell by -1.70% in the last day ( Friday, 14th Jun 2019 ) from $71.24 to $70.03 During day the stock fluctuated 2.58% from a day low at $69.77 to a day high of $71.57. The price has risen in 6 of the last 10 days and is up by 3.72% over the past 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -88 039 shares and in total 383 546 shares bought and sold for approximately $26.86 million.

Quick summary:

  • 30 day high of the ALNY stock price was $72.78 and low was $65.81.
  • 90 day high was $96.08 and low was $65.81.
  • 52 week high for the Alnylam Pharmaceuticals - $124.22 and low - $60.27.

Trend

Alnylam Pharmaceuticals lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -28.24% during the next 3 months and, with 90% probability hold a price between $41.17 and $53.43 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

There are few to none technical positive signals at the moment. Alnylam Pharmaceuticals holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $70.44 and $71.91. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Thursday June 13, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 55 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Alnylam Pharmaceuticals finds support from accumulated volume at $68.77.

Support: $68.77 Price: $70.03 Resistance: $70.82

Risk

This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $1.80 (2.58%) between high and low. For the last week, the stock has had a daily average volatility of 3.31%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

3.31 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Evaluation:

Alnylam Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Sell Candidate Downgraded
Stronger Sell Today ALNY ranks #4852 as SELL CANDIDATE #4852 Weaker Sell

Will ALNY stock price go up or down on Mon, 17 Jun 2019?

Predict

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank